MORGAN STANLEY PLC/CALL/STRYKER CORP./420/0.1/20.09.24 Stock

Warrant

DE000ME17RG7

Market Closed - Börse Stuttgart 03:07:41 2024-06-10 pm EDT
0.139 EUR -7.95% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./420/0.1/20.09.24
Current month+3.73%
1 month+7.75%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-10 0.139 -7.95%
24-06-07 0.151 +3.42%
24-06-06 0.146 +5.04%
24-06-05 0.139 0.00%
24-06-04 0.139 +0.72%

Delayed Quote Börse Stuttgart

Last update June 10, 2024 at 03:07 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME17RG
ISINDE000ME17RG7
Date issued 2023-09-27
Strike 420 $
Maturity 2024-09-20 (102 Days)
Parity 10 : 1
Emission price 0.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.7
Lowest since issue 0.04
Spread 0.035
Spread %18.32%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.2 USD
Average target price
373.1 USD
Spread / Average Target
+7.15%
Consensus